Physician

Amber Ingram Fresco, M.D.

According to 2025 Medicare claims, Amber Fresco, M.D. (NPI: 1588077499) practices dermatology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27713-8505. Fresco is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Fresco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 430 traditional Medicare patients, billed 1,555 HCPCS/CPT codes, and received $75,902 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 697 prescription claims across 195 beneficiaries totaling $1,242,579 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 1 records totaling $12,579. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,648 to $75,902. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,608 to $1,242,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$38K$76K2018 Medicare payment: $16,648 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $58,477 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $47,101 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $64,323 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $62,640 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $55,593 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $75,902 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018114316$16,648
20193761,424$58,477
20203111,087$47,101
20213531,258$64,323
20223241,128$62,640
20233261,062$55,593
20244301,555$75,902

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$621K$1.2M2015 Drug cost: $8,608 (USD; Tot_Drug_Cst)2016 Drug cost: $21,097 (USD; Tot_Drug_Cst)2017 Drug cost: $71,823 (USD; Tot_Drug_Cst)2018 Drug cost: $63,328 (USD; Tot_Drug_Cst)2019 Drug cost: $132,487 (USD; Tot_Drug_Cst)2020 Drug cost: $149,875 (USD; Tot_Drug_Cst)2021 Drug cost: $361,293 (USD; Tot_Drug_Cst)2022 Drug cost: $632,731 (USD; Tot_Drug_Cst)2023 Drug cost: $588,460 (USD; Tot_Drug_Cst)2024 Drug cost: $1,242,579 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201534127$8,608
201659200$21,097
201796365$71,823
2018124342$63,328
2019195658$132,487
2020169686$149,875
2021214691$361,293
2022229779$632,731
2023186507$588,460
2024195697$1,242,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more136168$81
11102Biopsy of related skin growth, first growth127144$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more219257$58
17000Destruction of precancer skin growth, 1 growth144174$34
17003Destruction of precancer skin growth, 2-14 growths101365$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab451,260$444,463
Humira(Cf) PenAdalimumab19532$290,833
OtezlaApremilast261,018$168,831
Humira(Cf)Adalimumab11308$72,393
Dupixent PenDupilumab14434$67,374

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.1$12,579UCB SA
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amber Ingram Fresco, M.D.?

Tedicare shows public-source Medicare data for Amber Ingram Fresco, M.D. (NPI 1588077499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amber Ingram Fresco, M.D. have ACO affiliation data?

Amber Ingram Fresco, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Amber Ingram Fresco, M.D.?

Amber Ingram Fresco, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Amber Ingram Fresco, M.D. have Open Payments data?

Amber Ingram Fresco, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.